Here, we showed the critical role of the DLK1/MEG3 locus in the differentiation of PitNETs in patients depending on the level of PIT1 and suggested the DLK1/MEG3 locus as a potential therapeutic target for somatotroph adenoma patients. This evidence concerns the gene MEG3 and growth hormone secreting pituitary adenoma 1.